Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Exploratory randomised double-blind controlled trial of breast milk fortifier with and without long chain polyunsaturated fatty acid (LCPUFA) supplementation on body composition in preterm infants
ISRCTN ISRCTN59878178
ClinicalTrials.gov identifier
Public title Exploratory randomised double-blind controlled trial of breast milk fortifier with and without long chain polyunsaturated fatty acid (LCPUFA) supplementation on body composition in preterm infants
Scientific title
Acronym N/A
Serial number at source N/A
Study hypothesis Breast milk fortifier containing LCPUFA has a measurable effect upon body composition at term when compared with non-LCPUFA supplemented fortifier
Lay summary
Ethics approval Not provided at time of registration.
Study design Randomised controlled trial
Countries of recruitment Germany
Disease/condition/study domain Preterm infants
Participants - inclusion criteria Infants born at or below 32 weeks gestational age
Participants - exclusion criteria 1. Major congenital abnormality

2. Mother does not wish to provide breast milk or to use donor milk
3. Baby requires gastrointestinal surgery
Anticipated start date 01/08/2005
Anticipated end date 30/06/2006
Status of trial Completed
Patient information material
Target number of participants 120 of whom 42 will be randomised
Interventions Infants will receive maternal +/- donor breast milk; should breast milk fortifier be indicated in accordance with normal clinical practice, infants will be randomised to receive standard fortifier or LCPUFA supplemented fortifier.
Primary outcome measure(s) Body composition at age term-equivalent
Secondary outcome measure(s) Growth, metabolic profile, intrahepatocellular lipid content, brain growth and development, neurological examination
Sources of funding Numico Research Germany
Trial website
Publications
Contact name Prof  Neena  Modi
  Address Imperial College London
Chelsea & Westminster Hospital
369 Fulham Road
  City/town London
  Zip/Postcode SW10 9NH
  Country United Kingdom
Sponsor Milupa GmbH, Numico Research (Germany)
  Address Bahnstrasse 14-30
  City/town Friedrichsdorf
  Zip/Postcode 61381
  Country Germany
Date applied 06/09/2005
Last edited 30/08/2007
Date ISRCTN assigned 13/09/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central